Subscribe To

Price Alert Latest News Economic Calendar News

IRTC / iRhythm Technologies to Report Second Quarter 2023 Financial Results on August 3, 2023

SAN FRANCISCO, July 20, 2023 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the second quarter 2023 after the close of trading on Thursday, August 3, 2023. The company's management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET. Read More

Demo Live Account See Partner Details

Content Topics

Irhythm

Technologies

Report

Second

Quarter

2023

Financial

2023 financial

Results

August

Stock

IRTC

Posted: Jul 20 2023, 16:05

Author Name: GlobeNewsWire

IRTC News

By Seeking Alpha
November 2, 2023

iRhythm Technologies, Inc. (IRTC) Q3 2023 Earnings Call Transcript

iRhythm Technologies, Inc. (NASDAQ:IRTC ) Q3 2023 Earnings Conference Call November 2, 2023 4:30 PM ET Company Participants Stephanie Zhadkevich - Dir

By Zacks Investment Research
October 27, 2023

Down -23.87% in 4 Weeks, Here's Why iRhythm Technologies (IRTC) Looks Ripe for a Turnaround

The heavy selling pressure might have exhausted for iRhythm Technologies (IRTC) as it is technically in oversold territory now. In addition to this te

By Zacks Investment Research
September 28, 2023

iRhythm Technologies (IRTC) Moves 7.4% Higher: Will This Strength Last?

iRhythm Technologies (IRTC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisi

By GlobeNewsWire
August 29, 2023

iRhythm Technologies to Participate in Two Investor Conferences in September

SAN FRANCISCO, Aug. 29, 2023 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating

By Zacks Investment Research
August 3, 2023

IRhythm Technologies (IRTC) Reports Q2 Loss, Tops Revenue Estimates

IRhythm Technologies (IRTC) came out with a quarterly loss of $0.61 per share versus the Zacks Consensus Estimate of a loss of $0.75. This compares to

By GlobeNewsWire
July 20, 2023

iRhythm Technologies to Report Second Quarter 2023 Financial Results on August 3, 2023

SAN FRANCISCO, July 20, 2023 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating t

By Seeking Alpha
May 26, 2023

iRhythm: Revolutionizing Arrhythmia Detection With AI And Machine Learning

iRhythm Technologies, Inc. is a key player in the US ambulatory cardiac monitoring market for arrhythmias. The company's Zio monitors utilize advanced

By Seeking Alpha
May 7, 2023

iRhythm Technologies, Inc. (IRTC) Q1 2023 Earnings Call Transcript

iRhythm Technologies, Inc. (NASDAQ:IRTC ) Q1 2023 Earnings Conference Call May 4, 2023 4:30 PM ET Company Participants Stephanie Zhadkevich - Director

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.